Inspire Biotherapeutics launches to target lung diseases through gene therapy
Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies…
March 16, 2023 - 2 minutes
Lung disease
Verona Pharma drug meets COPD phase 3 trial endpoints
Verona Pharma plc has announced positive results of its phase 3 ENHANCE-1 trial evaluating nebulized…
December 20, 2022 - 2 minutes
Enhertu’s positive results demonstrate improvement in overall survival
Enhertu, an antibody drug conjugate, being jointly developed by Daiichi Sankyo and AstraZeneca, has demonstrated…
December 8, 2022 - 4 minutes
More positive news announced for Verona’s COPD treatment
Clinical-stage biopharmaceutical company, Verona, has announced more positive news from its phase 3 ENHANCE-2 clinical…
October 17, 2022 - 3 minutes
Redx presents data confirming anti-fibrotic effects of lung disease drug
Redx Pharma has announced preclinical efficacy data in immune mediated models for RXC007. The data…
October 3, 2022 - 3 minutes
Sanofi and Regeneron’s Dupixent shows sustained improvement in lung function in children
A maintenance therapy from Sanofi and Regeneron, added to other asthma medications, has shown sustained…
September 5, 2022 - 3 minutes
Regulatory approval given to Iceland’s EpiEndo for study of COPD treatment
A treatment for chronic respiratory disorders will be the subject of a clinical trial in…
August 31, 2022 - 2 minutes
Vocal biomarker agreement set to benefit patients with COPD in India
A new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India…
August 24, 2022 - 3 minutes
Collaboration to advance investigational tuberculosis drug treatments
A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday…
August 18, 2022 - 5 minutes
Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
August 8, 2022 - 3 minutes
Additional funding for trial to study drug targeting lung immunity in elderly patients
Lung immunity in the elderly will be the subject of a controlled clinical trial after…
July 21, 2022 - 3 minutes
Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation
New data has been published today (July 7) evidencing findings that could lead to better…
July 7, 2022 - 4 minutes
